Erythropoietin Receptor Signaling through STAT3 Is Required for Glioma Stem Cell Maintenance

Recombinant erythropoietin (EPO) is a growth factor used in the treatment of chemotherapy-induced anemia, but recent studies suggest that EPO may accelerate cancer growth. Although several cancers express EPO receptors (EPORs), the mechanism by which EPOR promotes tumor growth remains poorly underst...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Cao, Yiting, Lathia, Justin D., Eyler, Christine E., Wu, Qiulian, Li, Zhizhong, Wang, Hui, McLendon, Roger E., Hjelmeland, Anita B., Rich, Jeremy N.
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2010
Assuntos:
Original Articles and Short Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2906804/
https://ncbi.nlm.nih.gov/pubmed/20657792
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1947601909356352
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados